UB Paderborn / Katalog / Suche / in CDI

Tomosynthesis-guided vacuum-assisted breast biopsy: A feasibility study

European radiology, 2016-06, Vol.26 (6), p.1582-1589

2016

Volltextzugriff (PDF)

Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?

Breast cancer research : BCR, 2004-01, Vol.6 (3), p.R191-R198, Article R191

2004

Volltextzugriff (PDF)

Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study

Breast cancer research and treatment, 2009-01, Vol.113 (1), p.129-136

2009

Volltextzugriff (PDF)

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

The lancet oncology, 2018-10, Vol.19 (10), p.1385-1393

2018

Volltextzugriff (PDF)

The Central-European SentiMag study: Sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope

Breast (Edinburgh), 2014-04, Vol.23 (2), p.175-179

2014

Volltextzugriff (PDF)

Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study

Annals of surgical oncology, 2007-06, Vol.14 (6), p.1896-1903

2007

Volltextzugriff (PDF)

Value of one-view breast tomosynthesis versus two-view mammography in diagnostic workup of women with clinical signs and symptoms and in women recalled from screening

American journal of roentgenology (1976), 2013-01, Vol.200 (1), p.226

2013

Volltextzugriff (PDF)

Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery : A prospective swiss multicenter study on 659 patients

Annals of surgery, 2007-03, Vol.245 (3), p.452-461

2007

Volltextzugriff (PDF)

Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer

JAMA surgery, 2023-10, Vol.158 (10), p.1013

2023

Volltextzugriff (PDF)

Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practice

Breast (Edinburgh), 2019-06, Vol.45, p.89-96

2019

Volltextzugriff (PDF)

Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Breast (Edinburgh), 2021-12, Vol.60, p.98-110

2021

Volltextzugriff (PDF)

Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Breast cancer research and treatment, 2023-09, Vol.201 (2), p.215-225

2023

Volltextzugriff (PDF)

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

Annals of oncology, 2004-06, Vol.15 (6), p.875-884

2004

Volltextzugriff (PDF)

Response to Barranger E, Ihrai T, response to the article by Thill et al.: “The Central-European SentiMag study: Sentinel lymph node biopsy with supermagnetic iron oxide (SPIO) vs. radioisotope”. The Breast 2014, 23(2):175–9

Breast (Edinburgh), 2014-10, Vol.23 (5), p.692-692

2014

Volltextzugriff (PDF)

Abstract PD15-11: PD15-11 Axillary dissection to determine nodal burden to inform systemic therapy recommendations in patients with clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.PD15-11-PD15-11

2023

Volltextzugriff (PDF)

Abstract P2-14-08: Trends in neoadjuvant systemic therapy rates in Europe: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P2-P2-14-08

2023

Volltextzugriff (PDF)

Bone Marrow Micrometastases Do Not Impact Disease-Free and Overall Survival in Early Stage Sentinel Lymph Node–Negative Breast Cancer Patients

Annals of surgical oncology, 2014-02, Vol.21 (2), p.401-407

2014

Volltextzugriff (PDF)

EGFR dependent expression of STAT3 (but not STAT1) in breast cancer

International journal of oncology, 2001-12, Vol.19 (6), p.1155

2001

Volltextzugriff (PDF)

Prognosis of dermal lymphatic invasion with or without clinical signs of inflammatory breast cancer

International journal of cancer, 2004-03, Vol.109 (1), p.144-148

2004

Volltextzugriff (PDF)

Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast

Oncology reports, 2002-09, Vol.9 (5), p.985

2002

Volltextzugriff (PDF)

Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer

International journal of oncology, 2002-07, Vol.21 (1), p.25

2002

Volltextzugriff (PDF)

Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer Patients with extracapsular invasion of axillary lymph-node metastases?

Strahlentherapie und Onkologie, 2003-10, Vol.179 (10), p.661-666

2003

Volltextzugriff (PDF)

Sites of failure in breast cancer patients with extracapsular invasion of axillary lymph node metastases. No need for axillary irradiation?

Strahlentherapie und Onkologie, 2005-09, Vol.181 (9), p.574-579

2005

Volltextzugriff (PDF)

Breast cancer surgery

Revue médicale suisse, 2007-10, Vol.3 (130), p.2389

2007

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Tomosynthesis-guided vacuum-assisted breast biopsy: A feasibility study

Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?

Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

The Central-European SentiMag study: Sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope

Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study

Value of one-view breast tomosynthesis versus two-view mammography in diagnostic workup of women with clinical signs and symptoms and in women recalled from screening

Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery : A prospective swiss multicenter study on 659 patients

Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer

Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practice

Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Impact of a Surgical Sealing Patch on Lymphatic Drainage After Axillary Dissection for Breast Cancer: The SAKK 23/13 Multicenter Randomized Phase III Trial

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

Response to Barranger E, Ihrai T, response to the article by Thill et al.: “The Central-European SentiMag study: Sentinel lymph node biopsy with supermagnetic iron oxide (SPIO) vs. radioisotope”. The Breast 2014, 23(2):175–9

Abstract PD15-11: PD15-11 Axillary dissection to determine nodal burden to inform systemic therapy recommendations in patients with clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Abstract P2-14-08: Trends in neoadjuvant systemic therapy rates in Europe: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Bone Marrow Micrometastases Do Not Impact Disease-Free and Overall Survival in Early Stage Sentinel Lymph Node–Negative Breast Cancer Patients

EGFR dependent expression of STAT3 (but not STAT1) in breast cancer

Prognosis of dermal lymphatic invasion with or without clinical signs of inflammatory breast cancer

Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast

Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer

Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer Patients with extracapsular invasion of axillary lymph-node metastases?

Sites of failure in breast cancer patients with extracapsular invasion of axillary lymph node metastases. No need for axillary irradiation?

Breast cancer surgery

Suchergebnisse filtern